Purchase Order 36C24222P0105
- Not listed
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $1,283,466.63 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for patient-specific chemotherapy compounding services. Avella, a subsidiary of UnitedHealth Group Incorporated, will provide specialized pharmacy services to support VA oncology and infusion treatment programs nationwide. The award is not associated with a set-aside designation. Avella has...
- The Department of Veterans Affairs (VA) has awarded a Delivery Order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $40,000.00 Firm Fixed Price contract is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Avella, which is a 503A certified pharmacy, will leverage its expertise in aseptic techniques for hazardous drug preparation to deliver customized...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a Firm Fixed Price Purchase Order worth $148,010.43 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of chemotherapy medication to support VA oncology and infusion treatment programs nationwide. The award does not have a set-aside designation. Optum Pharmacy 801, Inc. has received numerous federal contract...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $976,800.00 firm-fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the emergency compounding of hazardous chemotherapy drugs. The order was awarded on November 27, 2018 with a performance period through January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, provides specialized pharmacy services to support VA oncology and infusion...
- This federal contract award, valued at $230,297.50, was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the delivery of sterile compound supply services to support VA oncology and infusion treatment programs nationwide. As the prime contractor, Avella Specialty Pharmacy will compound customized chemotherapy and other...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $699,995.00 firm fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the provision of emergency compounded chemotherapy drugs. The period of performance was from February 1, 2019 to April 30, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, has received numerous VA-VHA awards to provide specialized pharmacy services involving chemotherapy and...
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
- The Department of Veterans Affairs Veterans Health Administration awarded a $100,000 firm fixed price blanket purchase agreement call contract to Optum Pharmacy 801, Inc. d/b/a Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group, to provide chemotherapy compound chemical mixes. The place of performance will be Avella's facility located in Phoenix, Arizona. The one-year contract starts on August 24, 2023 and concludes on August 23, 2024. As the prime contractor, Avella will be...
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, to provide compounded chemotherapy agents. The $576,800.00 firm fixed price purchase order has a completion date of January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, specializes in hazardous sterile compounding and has received numerous prior awards from the VA-VHA to supply customized cancer...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $1,875,405.34 contract is for the provision of compounded chemotherapy drugs to support VA oncology and infusion treatment programs at the VA Long Beach Healthcare System in California. The contract period of performance is April 2, 2019 to...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service Networks (VISNs) and medical centers across the country that administer healthcare services for veterans. No set-aside designation was used for this award. Avella also holds several federal Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with the VA-VHA to provide specialized pharmacy compounding services, including a $10 million IDC for regional support in Texas and a $2.5 million multi-year BPA utilizing Avella's Phoenix headquarters to compound chemotherapy for distribution across the VA's national health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($12k) | 3/3/22 | |
| Not listed | Not listed | $200.0k | 10/28/21 |